{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T14:13:07Z","timestamp":1783174387517,"version":"3.54.6"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K23-AR084603"],"award-info":[{"award-number":["K23-AR084603"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Skeletal Radiol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00256-024-04859-1","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T02:16:07Z","timestamp":1736302567000},"page":"2265-2274","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Imaging and management of calcium pyrophosphate deposition disease"],"prefix":"10.1007","volume":"54","author":[{"given":"Wasim","family":"Issa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Mercer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janeth","family":"Yinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Guermazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8095-0174","authenticated-orcid":false,"given":"Mohamed","family":"Jarraya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"key":"4859_CR1","doi-asserted-by":"publisher","first-page":"738","DOI":"10.7326\/0003-4819-56-5-738","volume":"56","author":"NN Kohn","year":"1962","unstructured":"Kohn NN. The significance of calcium phosphate crystals in the synovial fluid of arthritic patients: the \u2018pseudogout syndrome\u2019: II. Identification of Crystals Ann Intern Med. 1962;56:738.","journal-title":"Identification of Crystals Ann Intern Med"},{"key":"4859_CR2","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1007\/s00256-022-04246-8","volume":"52","author":"M Jarraya","year":"2023","unstructured":"Jarraya M, Roemer F, Kwoh CK, Guermazi A. Crystal arthropathies and osteoarthritis\u2014where is the link? Skeletal Radiol. 2023;52:2037\u201343.","journal-title":"Skeletal Radiol"},{"key":"4859_CR3","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1002\/art.42619","volume":"75","author":"A Abhishek","year":"2023","unstructured":"Abhishek A, et al. The 2023 ACR\/ EULAR classification criteria for calcium pyrophosphate deposition disease. Arthritis Rheumatol. 2023;75:1703\u201313.","journal-title":"Arthritis Rheumatol"},{"key":"4859_CR4","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1136\/ard.62.6.513","volume":"62","author":"RL Neame","year":"2003","unstructured":"Neame RL. UK community prevalence of knee chondrocalcinosis: evidence that correlation with osteoarthritis is through a shared association with osteophyte. Ann Rheum Dis. 2003;62:513\u20138.","journal-title":"Ann Rheum Dis"},{"key":"4859_CR5","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1002\/art.1780400420","volume":"40","author":"DT Felson","year":"1997","unstructured":"Felson DT, et al. Risk factors for incident radiographic knee osteoarthritis in the elderly. Framingham Study Arthritis Rheum. 1997;40:728\u201333.","journal-title":"Framingham Study Arthritis Rheum"},{"key":"4859_CR6","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.joca.2023.04.004","volume":"31","author":"M Jarraya","year":"2023","unstructured":"Jarraya M, et al. Prevalence of intra-articular mineralization on knee computed tomography: the multicenter osteoarthritis study. Osteoarthritis Cartilage. 2023;31:1111\u201320.","journal-title":"Osteoarthritis Cartilage"},{"key":"4859_CR7","first-page":"981","volume":"27","author":"R Ramonda","year":"2009","unstructured":"Ramonda R, et al. Prevalence of chondrocalcinosis in Italian subjects from northeastern Italy. The Pro.V.A. (PROgetto Veneto Anziani) study. Clin Exp Rheumatol. 2009;27:981\u20134.","journal-title":"Clin Exp Rheumatol"},{"key":"4859_CR8","unstructured":"Salaffi, F., De Angelis, R., Grassi, W., MArche Pain Prevalence, & INvestigation Group (MAPPING) study. Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study. Clin Exp Rheumatol 2005; 23, 819\u2013828"},{"key":"4859_CR9","doi-asserted-by":"publisher","unstructured":"Pascart T et al Calcium pyrophosphate deposition disease. Lancet Rheumatol. S266599132400122X (2024) https:\/\/doi.org\/10.1016\/S2665-9913(24)00122-X","DOI":"10.1016\/S2665-9913(24)00122-X"},{"key":"4859_CR10","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1136\/ard.2010.139105","volume":"70","author":"terminology and diagnosis","year":"2011","unstructured":"terminology and diagnosis. Zhang, W. et al. European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I. Ann Rheum Dis. 2011;70:563\u201370.","journal-title":"Ann Rheum Dis"},{"key":"4859_CR11","first-page":"33","volume":"15","author":"S Cowley","year":"2023","unstructured":"Cowley S, McCarthy G. Diagnosis and treatment of calcium pyrophosphate deposition (CPPD) disease: a review. Open Access Rheumatol Res Rev. 2023;15:33\u201341.","journal-title":"Open Access Rheumatol Res Rev"},{"key":"4859_CR12","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1093\/rheumatology\/keac063","volume":"61","author":"E Cipolletta","year":"2022","unstructured":"Cipolletta E, et al. Ultrasound findings of calcium pyrophosphate deposition disease at metacarpophalangeal joints. Rheumatology. 2022;61:3997\u20134005.","journal-title":"Rheumatology"},{"key":"4859_CR13","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1002\/art.1780280507","volume":"28","author":"PA Gibilisco","year":"1985","unstructured":"Gibilisco PA, Schumacher HR, Hollander JL, Soper KA. Synovial fluid crystals in osteoarthritis. Arthritis Rheum. 1985;28:511\u20135.","journal-title":"Arthritis Rheum"},{"key":"4859_CR14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1053\/joca.2002.0861","volume":"11","author":"S Nalbant","year":"2003","unstructured":"Nalbant S, et al. Synovial fluid features and their relations to osteoarthritis severity: new findings from sequential studies. Osteoarthritis Cartilage. 2003;11:50\u20134.","journal-title":"Osteoarthritis Cartilage"},{"key":"4859_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1136\/ard.52.2.97","volume":"52","author":"M Pattrick","year":"1993","unstructured":"Pattrick M, Hamilton E, Wilson R, Austin S, Doherty M. Association of radiographic changes of osteoarthritis, symptoms, and synovial fluid particles in 300 knees. Ann Rheum Dis. 1993;52:97\u2013103.","journal-title":"Ann Rheum Dis"},{"key":"4859_CR16","first-page":"64","volume":"109","author":"D Ivory","year":"2012","unstructured":"Ivory D, Vel\u00e1zquez CR. The forgotten crystal arthritis: calcium pyrophosphate deposition. Mo Med. 2012;109:64\u20138.","journal-title":"Mo Med"},{"key":"4859_CR17","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1148\/rg.2018180048","volume":"38","author":"DV Flores","year":"2018","unstructured":"Flores DV, Mej\u00eda G\u00f3mez C, Pathria MN. Layered approach to the anterior knee: normal anatomy and disorders associated with anterior knee pain. RadioGraphics. 2018;38:2069\u2013101.","journal-title":"RadioGraphics"},{"key":"4859_CR18","unstructured":"Brower AC, Flemming DJ. Arthritis in Black and White. Philadelphia: Elsevier Saunders; 2012"},{"key":"4859_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1469-7580.2006.00504.x","volume":"208","author":"RS Lee","year":"2006","unstructured":"Lee RS, Kayser MV, Ali SY. Calcium phosphate microcrystal deposition in the human intervertebral disc. J Anat. 2006;208:13\u20139.","journal-title":"J Anat"},{"key":"4859_CR20","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10067-007-0754-3","volume":"27","author":"T Yayama","year":"2008","unstructured":"Yayama T, et al. Calcium pyrophosphate crystal deposition in the ligamentum flavum of degenerated lumbar spine: histopathological and immunohistological findings. Clin Rheumatol. 2008;27:597\u2013604.","journal-title":"Clin Rheumatol"},{"key":"4859_CR21","doi-asserted-by":"publisher","first-page":"470","DOI":"10.25259\/SNI_684_2022","volume":"13","author":"M Ehioghae","year":"2022","unstructured":"Ehioghae M, Lawlor MC, Mesfin A. Calcium pyrophosphate dihydrate of the ligamentum flavum in the cervical spine \u2013 a review of the literature. Surg Neurol Int. 2022;13:470.","journal-title":"Surg Neurol Int"},{"key":"4859_CR22","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/00007632-199602150-00019","volume":"21","author":"AD Markiewitz","year":"1996","unstructured":"Markiewitz AD, Boumphrey FR, Bauer TW, Bell GR. Calcium pyrophosphate dihydrate crystal deposition disease as a cause of lumbar canal stenosis. Spine. 1996;21:506\u201311.","journal-title":"Spine"},{"key":"4859_CR23","first-page":"100026","volume":"3","author":"AS Moon","year":"2020","unstructured":"Moon AS, Mabry S, Pittman JL. Calcium pyrophosphate deposition disease of the cervical and thoracolumbar spine: a report of two cases. North Am Spine Soc J. 2020;3:100026.","journal-title":"North Am Spine Soc J"},{"key":"4859_CR24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neuchi.2013.03.003","volume":"59","author":"M Godfrin-Valnet","year":"2013","unstructured":"Godfrin-Valnet M, et al. Eighteen cases of crowned dens syndrome: presentation and diagnosis. Neurochirurgie. 2013;59:115\u201320.","journal-title":"Neurochirurgie"},{"key":"4859_CR25","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1056\/NEJMra1511117","volume":"374","author":"AK Rosenthal","year":"2016","unstructured":"Rosenthal AK, Ryan LM. Calcium pyrophosphate deposition disease. N Engl J Med. 2016;374:2575\u201384.","journal-title":"N Engl J Med"},{"key":"4859_CR26","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/s41379-021-00786-x","volume":"34","author":"YJ Liu","year":"2021","unstructured":"Liu YJ, et al. Calcified chondroid mesenchymal neoplasms with FN1-receptor tyrosine kinase gene fusions including FGFR2, FGFR1, MERTK, NTRK1, and TEK: a molecular and clinicopathologic analysis. Mod Pathol. 2021;34:1373\u201383.","journal-title":"Mod Pathol"},{"key":"4859_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41584-022-00875-4","volume":"19","author":"I Bernabei","year":"2023","unstructured":"Bernabei I, So A, Busso N, Nasi S. Cartilage calcification in osteoarthritis: mechanisms and clinical relevance. Nat Rev Rheumatol. 2023;19:10\u201327.","journal-title":"Nat Rev Rheumatol"},{"key":"4859_CR28","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1136\/ard.36.2.146","volume":"36","author":"MH Pritchard","year":"1977","unstructured":"Pritchard MH, Jessop JD. Chondrocalcinosis in primary hyperparathyroidism Influence of age, metabolic bone disease, and parathyroidectomy. Ann Rheum Dis. 1977;36:146\u201351.","journal-title":"Ann Rheum Dis"},{"key":"4859_CR29","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1002\/art.23106","volume":"57","author":"P Richette","year":"2007","unstructured":"Richette P, et al. Hypomagnesemia associated with chondrocalcinosis: a cross-sectional study. Arthritis Care Res. 2007;57:1496\u2013501.","journal-title":"Arthritis Care Res"},{"key":"4859_CR30","first-page":"1108","volume":"35","author":"C Muehleman","year":"2008","unstructured":"Muehleman C, et al. Association between crystals and cartilage degeneration in the ankle. J Rheumatol. 2008;35:1108\u201317.","journal-title":"J Rheumatol"},{"key":"4859_CR31","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.joca.2019.10.003","volume":"28","author":"SC Foreman","year":"2020","unstructured":"Foreman SC, et al. Chondrocalcinosis is associated with increased knee joint degeneration over 4 years: data from the Osteoarthritis Initiative. Osteoarthritis Cartilage. 2020;28:201\u20137.","journal-title":"Osteoarthritis Cartilage"},{"key":"4859_CR32","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1002\/art.42832","volume":"76","author":"JW Liew","year":"2024","unstructured":"Liew JW, et al. Intra-articular mineralization on computerized tomography of the knee and risk of cartilage damage: the multicenter osteoarthritis study. Arthritis Rheumatol. 2024;76:1054\u201361.","journal-title":"Arthritis Rheumatol"},{"key":"4859_CR33","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1002\/art.42649","volume":"75","author":"JW Liew","year":"2023","unstructured":"Liew JW, et al. Relation of intra-articular mineralization to knee pain in knee osteoarthritis: a longitudinal analysis in the MOST study. Arthritis Rheumatol. 2023;75:2161\u20138.","journal-title":"Arthritis Rheumatol"},{"key":"4859_CR34","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1002\/art.21903","volume":"54","author":"T Neogi","year":"2006","unstructured":"Neogi T, et al. Lack of association between chondrocalcinosis and increased risk of cartilage loss in knees with osteoarthritis: results of two prospective longitudinal magnetic resonance imaging studies. Arthritis Rheum. 2006;54:1822\u20138.","journal-title":"Arthritis Rheum"},{"key":"4859_CR35","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s41584-018-0078-5","volume":"14","author":"GM McCarthy","year":"2018","unstructured":"McCarthy GM, Dunne A. Calcium crystal deposition diseases \u2014 beyond gout. Nat Rev Rheumatol. 2018;14:592\u2013602.","journal-title":"Nat Rev Rheumatol"},{"key":"4859_CR36","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/BOR.0000000000000246","volume":"28","author":"A Abhishek","year":"2016","unstructured":"Abhishek A. Calcium pyrophosphate deposition disease: a review of epidemiologic findings. Curr Opin Rheumatol. 2016;28:133\u20139.","journal-title":"Curr Opin Rheumatol"},{"key":"4859_CR37","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1002\/acr.24898","volume":"75","author":"SK Tedeschi","year":"2023","unstructured":"Tedeschi SK, et al. Imaging features of calcium pyrophosphate deposition disease: consensus definitions from an international multidisciplinary working group. Arthritis Care Res. 2023;75:825\u201334.","journal-title":"Arthritis Care Res"},{"key":"4859_CR38","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/art.42368","volume":"75","author":"S Sirotti","year":"2023","unstructured":"Sirotti S, et al. Reliability and diagnostic accuracy of radiography for the diagnosis of calcium pyrophosphate deposition: performance of the novel definitions developed by an international multidisciplinary working group. Arthritis Rheumatol. 2023;75:630\u20138.","journal-title":"Arthritis Rheumatol"},{"key":"4859_CR39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/gucdd2010002","volume":"2","author":"G Filippou","year":"2024","unstructured":"Filippou G, Sirotti S, Cipolletta E, Filippucci E. Optimizing the use of ultrasound in calcium pyrophosphate deposition (CPPD): a review from the ground up. Gout Urate Cryst Depos Dis. 2024;2:17\u201333.","journal-title":"Gout Urate Cryst Depos Dis"},{"key":"4859_CR40","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.joca.2021.01.007","volume":"29","author":"E Cipolletta","year":"2021","unstructured":"Cipolletta E, et al. The diagnostic value of conventional radiography and musculoskeletal ultrasonography in calcium pyrophosphate deposition disease: a systematic literature review and meta-analysis. Osteoarthritis Cartilage. 2021;29:619\u201332.","journal-title":"Osteoarthritis Cartilage"},{"key":"4859_CR41","doi-asserted-by":"publisher","first-page":"e474","DOI":"10.1016\/S2665-9913(23)00136-4","volume":"5","author":"S Sirotti","year":"2023","unstructured":"Sirotti S, et al. Development and validation of an OMERACT ultrasound scoring system for the extent of calcium pyrophosphate crystal deposition at the joint level and patient level. Lancet Rheumatol. 2023;5:e474\u201382.","journal-title":"Lancet Rheumatol"},{"key":"4859_CR42","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.joca.2020.03.003","volume":"28","author":"A Guermazi","year":"2020","unstructured":"Guermazi A, et al. Reliability of a new scoring system for intraarticular mineralization of the knee: Boston University Calcium Knee Score (BUCKS). Osteoarthritis Cartilage. 2020;28:802\u201310.","journal-title":"Osteoarthritis Cartilage"},{"key":"4859_CR43","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1136\/ard-2023-224771","volume":"83","author":"P Mandl","year":"2024","unstructured":"Mandl P, et al. 2023 EULAR recommendations on imaging in diagnosis and management of crystal-induced arthropathies in clinical practice. Ann Rheum Dis. 2024;83:752\u20139.","journal-title":"Ann Rheum Dis"},{"key":"4859_CR44","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13018-018-0787-0","volume":"13","author":"H Tanikawa","year":"2018","unstructured":"Tanikawa H, et al. Detection of calcium pyrophosphate dihydrate crystals in knee meniscus by dual-energy computed tomography. J Orthop Surg. 2018;13:73.","journal-title":"J Orthop Surg"},{"key":"4859_CR45","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/art.41569","volume":"73","author":"J Budzik","year":"2021","unstructured":"Budzik J, et al. Can dual-energy computed tomography be used to identify early calcium crystal deposition in the knees of patients with calcium pyrophosphate deposition? Arthritis Rheumatol. 2021;73:687\u201392.","journal-title":"Arthritis Rheumatol"},{"key":"4859_CR46","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1093\/rheumatology\/kez431","volume":"59","author":"SK Tedeschi","year":"2020","unstructured":"Tedeschi SK, et al. A prospective study of dual-energy CT scanning, US and X-ray in acute calcium pyrophosphate crystal arthritis. Rheumatology. 2020;59:900\u20133.","journal-title":"Rheumatology"},{"key":"4859_CR47","doi-asserted-by":"publisher","first-page":"100436","DOI":"10.1016\/j.ocarto.2024.100436","volume":"6","author":"M Jarraya","year":"2024","unstructured":"Jarraya M, et al. Dual energy computed tomography cannot effectively differentiate between calcium pyrophosphate and basic calcium phosphate diseases in the clinical setting. Osteoarthr Cartil Open. 2024;6:100436.","journal-title":"Osteoarthr Cartil Open"},{"key":"4859_CR48","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/RLI.0000000000000756","volume":"56","author":"A D\u00f8ssing","year":"2021","unstructured":"D\u00f8ssing A, et al. Dual-energy computed tomography for detection and characterization of monosodium urate, calcium pyrophosphate, and hydroxyapatite: a phantom study on diagnostic performance. Invest Radiol. 2021;56:417\u201324.","journal-title":"Invest Radiol"},{"key":"4859_CR49","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.3840","author":"SM Iqbal","year":"2019","unstructured":"Iqbal SM, Qadir S, Aslam HM, Qadir MA. Updated treatment for calcium pyrophosphate deposition disease: an insight. Cureus. 2019. https:\/\/doi.org\/10.7759\/cureus.3840.","journal-title":"Cureus"},{"key":"4859_CR50","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1136\/ard.42.Suppl_1.106","volume":"42","author":"M Doherty","year":"1983","unstructured":"Doherty M, Dieppe PA. Double blind, placebo controlled trial of magnesium carbonate in chronic pyrophosphate arthropathy. Ann Rheum Dis. 1983;42:106\u20137.","journal-title":"Ann Rheum Dis"},{"key":"4859_CR51","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.semarthrit.2020.10.005","volume":"51","author":"K Parperis","year":"2021","unstructured":"Parperis K, Papachristodoulou E, Kakoullis L, Rosenthal AK. Management of calcium pyrophosphate crystal deposition disease: a systematic review. Semin Arthritis Rheum. 2021;51:84\u201394.","journal-title":"Semin Arthritis Rheum"},{"key":"4859_CR52","first-page":"1001","volume":"38","author":"E Cipolletta","year":"2020","unstructured":"Cipolletta E, et al. Biologics in the treatment of calcium pyrophosphate deposition disease: a systematic literature review. Clin Exp Rheumatol. 2020;38:1001\u20137.","journal-title":"Clin Exp Rheumatol"},{"key":"4859_CR53","doi-asserted-by":"publisher","first-page":"105088","DOI":"10.1016\/j.jbspin.2020.105088","volume":"88","author":"A Dumusc","year":"2021","unstructured":"Dumusc A, et al. Anakinra compared to prednisone in the treatment of acute CPPD crystal arthritis: a randomized controlled double-blinded pilot study. Joint Bone Spine. 2021;88:105088.","journal-title":"Joint Bone Spine"},{"key":"4859_CR54","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1136\/annrheumdis-2020-217188","volume":"79","author":"A Latourte","year":"2020","unstructured":"Latourte A, et al. Tocilizumab in symptomatic calcium pyrophosphate deposition disease: a pilot study. Ann Rheum Dis. 2020;79:1126\u20138.","journal-title":"Ann Rheum Dis"},{"key":"4859_CR55","doi-asserted-by":"publisher","first-page":"e523","DOI":"10.1016\/S2665-9913(23)00165-0","volume":"5","author":"T Pascart","year":"2023","unstructured":"Pascart T, et al. Evaluating the safety and short-term equivalence of colchicine versus prednisone in older patients with acute calcium pyrophosphate crystal arthritis (COLCHICORT): an open-label, multicentre, randomised trial. Lancet Rheumatol. 2023;5:e523\u201331.","journal-title":"Lancet Rheumatol"},{"key":"4859_CR56","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1186\/s13075-014-0458-4","volume":"16","author":"A Finckh","year":"2014","unstructured":"Finckh A, et al. Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial. Arthritis Res Ther. 2014;16:458.","journal-title":"Arthritis Res Ther"},{"key":"4859_CR57","first-page":"327","volume":"23","author":"B Rothschild","year":"1997","unstructured":"Rothschild B, Yakubov LE. Prospective 6-month, double-blind trial of hydroxychloroquine treatment of CPDD. Compr Ther. 1997;23:327\u201331.","journal-title":"Compr Ther"},{"key":"4859_CR58","doi-asserted-by":"publisher","unstructured":"Damart J et al Retention, safety and efficacy of off-label conventional treatments and biologics for chronic calcium pyrophosphate crystal inflammatory arthritis. Rheumatology kead228 (2023) https:\/\/doi.org\/10.1093\/rheumatology\/kead228.","DOI":"10.1093\/rheumatology\/kead228"},{"key":"4859_CR59","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/RHU.0b013e3182611471","volume":"18","author":"M Andres","year":"2012","unstructured":"Andres M, Sivera F, Pascual E. Methotrexate Is an option for patients with refractory calcium pyrophosphate crystal arthritis. JCR J Clin Rheumatol. 2012;18:234\u20136.","journal-title":"JCR J Clin Rheumatol"}],"container-title":["Skeletal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00256-024-04859-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00256-024-04859-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00256-024-04859-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T10:02:44Z","timestamp":1758708164000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00256-024-04859-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,8]]},"references-count":59,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["4859"],"URL":"https:\/\/doi.org\/10.1007\/s00256-024-04859-1","relation":{},"ISSN":["0364-2348","1432-2161"],"issn-type":[{"value":"0364-2348","type":"print"},{"value":"1432-2161","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,8]]},"assertion":[{"value":"17 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A.G. is shareholder of BICL, LLC and consultant to Novartis, TissueGene, Coval, Medipost, Formation Bio, Pacira, ICM, Levicept, 4Moving Biotech, Peptinov, and Scarcell Therapeutics. W.I., J.Y. and M.J and have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}